The cut of this gentleman's mustache, with the two premature wrinkles in the cheek above it, and the fashion of his garments, in which an exposed shirt-front and a cerulean
cravat played perhaps an obtrusive part, completed the conditions of his identity.
The moon, rising behind the rocks, unrolled a silver sheet on the cerulean
carpet of the sea.
The street that they were following suddenly opened upon a wide avenue, and before them spread a broad and beautiful lagoon, the quiet surface of which mirrored the clear cerulean
of the sky.
Like the rest of our waters, when much agitated, in clear weather, so that the surface of the waves may reflect the sky at the right angle, or because there is more light mixed with it, it appears at a little distance of a darker blue than the sky itself; and at such a time, being on its surface, and looking with divided vision, so as to see the reflection, I have discerned a matchless and indescribable light blue, such as watered or changeable silks and sword blades suggest, more cerulean
than the sky itself, alternating with the original dark green on the opposite sides of the waves, which last appeared but muddy in comparison.
Looking round him, he there beheld a signboard on which the painter's art had delineated something remotely resembling a cerulean
elephant with an aquiline nose in lieu of trunk.
On 19 March, DarA(c) Bioscience and Cerulean
Pharma announced they had entered into a stock purchase agreement with equity holders of DarA(c) allowing DarA(c) to become majority owner of Cerulean
, the company said.
M2 EQUITYBITES-June 28, 2017-US Drugmaker Cerulean
Pharma Urges Shareholders to Vote for DarA(c) Bioscience Buyout at 19 July Meeting
United States-based Cerulean
Pharma has received orphan drug designation for its nanoparticle-drug conjugate, CRLX101, from the United States Food and Drug Administration, it was reported on Tuesday.
FRESH from a triumph at Glorious Goodwood last week, in-form filly Cerulean
Rose attempts to land her fourth win in 19 days at Bath today, writes Roy Briggs.